A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment
- PMID: 27893929
- PMCID: PMC5339042
- DOI: 10.1002/cncr.30423
A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment
Abstract
The American Society of Clinical Oncology released its first guidance statement on the cost of cancer care in August 2009, affirming that patient-physician cost communication is a critical component of high-quality care. This forward-thinking recommendation has grown increasingly important in oncology practice today as the high costs of cancer care impose tremendous financial burden to patients, their families, and the health care system. For the current review, a literature search was conducted using the PubMed and Web of Science databases to identify articles that covered 3 topics related to patient-physician cost communication: patient attitude, physician acceptance, and the associated outcomes; and 15 articles from 12 distinct studies were identified. Although most articles that addressed patient attitude suggested that cost communication is desired by >50% of patients in the respective study cohorts, only <33% of patients in those studies had actually discussed costs with their physicians. The literature on physician acceptance indicated that, although 75% of physicians considered discussions of out-of-pocket costs with patients their responsibility, <30% felt comfortable with such communication. When asked about whether cost communication actually took place in their practice, percentages reported by physicians varied widely from <10% to >60%. The data suggested that cost communication was associated with improved patient satisfaction, lower out-of-pocket expenses, and a higher likelihood of medication nonadherence; none of the studies established causality. Both patients and physicians expressed a strong need for accurate, accessible, and transparent information about the cost of cancer care. Cancer 2017;123:928-39. © 2016 American Cancer Society.
Keywords: cost transparency; outcomes; patient attitudes; patient-physician cost communication; physician acceptance.
© 2016 American Cancer Society.
Figures
Similar articles
-
American Society of Clinical Oncology guidance statement: the cost of cancer care.J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6. J Clin Oncol. 2009. PMID: 19581533
-
Patient-physician communication about out-of-pocket costs.JAMA. 2003 Aug 20;290(7):953-8. doi: 10.1001/jama.290.7.953. JAMA. 2003. PMID: 12928475
-
Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.J Oncol Pract. 2016 Mar;12(3):e281-8, 247-8. doi: 10.1200/JOP.2015.007401. Epub 2016 Feb 16. J Oncol Pract. 2016. PMID: 26883407 Free PMC article.
-
Cost of cancer care: the patient perspective.J Clin Oncol. 2007 Jan 10;25(2):228-32. doi: 10.1200/JCO.2006.07.9111. J Clin Oncol. 2007. PMID: 17210945 Review.
-
The financial burden of cancer care: do patients in the US know what to expect?Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):835-42. doi: 10.1586/14737167.2014.963558. Epub 2014 Oct 1. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 25269513 Review.
Cited by
-
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.Blood Adv. 2024 Oct 8;8(19):5146-5155. doi: 10.1182/bloodadvances.2024012998. Blood Adv. 2024. PMID: 39146495 Free PMC article.
-
The utility of value frameworks in cost communications: making them real for patients.J Natl Cancer Inst. 2024 Sep 1;116(9):1411-1413. doi: 10.1093/jnci/djae156. J Natl Cancer Inst. 2024. PMID: 39003520 No abstract available.
-
National survey of patient perspectives on cost discussions among recipients of copay assistance.Oncologist. 2024 Jun 12:oyae148. doi: 10.1093/oncolo/oyae148. Online ahead of print. Oncologist. 2024. PMID: 38864681
-
Financial Toxicity in Radiation Oncology: Impact for Our Patients and for Practicing Radiation Oncologists.Adv Radiat Oncol. 2023 Dec 10;9(3):101419. doi: 10.1016/j.adro.2023.101419. eCollection 2024 Mar. Adv Radiat Oncol. 2023. PMID: 38379894 Free PMC article. Review.
-
Care Delivery Interventions for Individuals with Cancer: A Literature Review and Focus on Gastrointestinal Malignancies.Healthcare (Basel). 2023 Dec 22;12(1):30. doi: 10.3390/healthcare12010030. Healthcare (Basel). 2023. PMID: 38200936 Free PMC article. Review.
References
-
- Hillner BE, Smith TJ. Do the large benefits justify the large costs of adjuvant breast cancer trastuzumab? J Clin Oncol. 2007;25:611–613. - PubMed
-
- Schrag D. The price tag on progress--chemotherapy for colorectal cancer. N Engl J Med. 2004;351:317–319. - PubMed
-
- Scalo JF, Rascati KL. Trends and issues in oncology costs. Expert Rev Pharmacoecon Outcomes Res. 2014;14:35–44. - PubMed
-
- Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27:3868–3874. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
